期刊文献+

整合素αV和β3反义基因抑制大鼠胰腺癌生长的实验研究 被引量:7

Antisense intergrin αV and integrin β3 suppresses the growth of pancreatic carcinoma in rats
下载PDF
导出
摘要 目的:探讨整合素αV和β3反义基因对大鼠胰腺癌生长及肿瘤血管生成和细胞凋亡的影响。方法:建立大鼠胰腺癌模型,应用电转染方法分别用整合素αV、β3及αVβ3反义基因治疗,观察治疗后抑瘤率并应用免疫组织化学技术检测肿瘤微血管密度变化,TUNEL法检测肿瘤细胞凋亡情况。结果:对照组、αV组、β3组及αVβ3组肿瘤质量分别为(1.17±0.79)g、(0.95±0.26)g、(1.013±0.42)g和(0.79±0.56)g,各组间差异有统计学意义(P<0.05);微血管密度分别为(18.33±1.39)、(13.80±1.06)、(15.96±1.24)和(12.16±1.23),各组间差异有统计学意义(P<0.05);肿瘤细胞凋亡指数分别为(12.30±1.393)、(22.17±1.23)、(20.37±1.07)和(24.10±0.99),各组间差异有统计学意义(P<0.01)。结论:整合素αV、β3反义基因对大鼠胰腺癌的血管生长具有明显的抑制作用,可促进肿瘤细胞的凋亡,进而影响肿瘤生长,联合应用整合素αVβ3对肿瘤的生长抑制作用更为显著。 Objective: To investigate antisenSe integrin αV and β3 gene therapy in Rats model of Pancreatic Carcinoma. Methodsz The antisense integrin α V and β3 expression plasmids were electrobloted into pancreatic tumours of rats induced by dimethylbenxanthracine,The tumor inhibit rate was calculated,the tumor microvessel density(MVD)with the immunohistochemical staining and tumor apoptosis with TUNEL were examined.Redults:The tumor weight of the control group αV group,β3group and αVβ3 group was (1.167±0.79)g,(0.953±0.26)g,(1.013±0.42)g,(0.788±0.56)g respectively.The difference was significant among them(P〈0.05).The MVD was (18.33±1.39),(13.80±1.06),(15.96±1.24),(12,16±1.23)respectively,there was significant difference among them(P〈0.05).The Al was (12.30±1.393)、(22.17±1.23),(20.37±1.07),(24.10±0.99)respectively and there was significant difference among them(P〈0.05).Conclusions:Antisense gene therapy targeting integrin αV and β3 should be considered as an approach to suppress the growth of pancreatic carcinoma.
出处 《中国现代普通外科进展》 CAS 2008年第6期474-476,480,共4页 Chinese Journal of Current Advances in General Surgery
基金 山东省科技攻关课题(2005GG4402052)
关键词 整合素类 胰腺肿瘤 血管生成 细胞凋亡 基因治疗 I ntegdnso Pancreatic neoplasms .Cell apoptosis Gene therapy Angiogenesis
  • 相关文献

参考文献12

  • 1方全.整合素与血管生成[J].国外医学(免疫学分册),2002,25(1):17-20. 被引量:5
  • 2贾欣永,李杰,徐宗珍,韩旭,张强波,时昌文.整合素αV、β3反义基因抑制裸鼠种植性肝癌血管生成的实验研究[J].中国现代普通外科进展,2007,10(2):153-155. 被引量:3
  • 3Sun X, Kanwar JR, Leung E, et al. Gene transfer of antisense hypoxia inducible factor-1 enhances the therapeutic efficacy of cancer immunotherapy[J]. Gene Ther,2001,8 (8) : 638-45.
  • 4Li J, Tan H, Dong X, et al. Antisense integrin αV and β3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas[J]. Diecstive and Liver Disease, 2007,39 (5) :557-565.
  • 5秦仁义,爱德,邹声泉,刘仁则,李飞,吴在德,裘法祖.一种新型大鼠胰腺癌模型的制备[J].中华实验外科杂志,2000,17(5):462-463. 被引量:31
  • 6李朝阳,张曙光,于振海,孙京杰,时昌文,阮长乐.大鼠胰腺癌模型制备的实验研究[J].中国现代普通外科进展,2005,8(2):102-103. 被引量:3
  • 7Kawasaki H, Toyoda M, Shinaohara H, et al. Expression of survivin correlates with apoptosis, proliferation and angiogenesis during human colorectal tumorigenesis[J]. Cancer, 2001,91 ( 11 ) :2026-2032.
  • 8Tanigawa N, Lu C, Mitsui T et al. Quantitation of sinusoid-like Vessels in hepatocellular carcinoma: its clinical and prognostic significance[J]. Hepatology, 1997,26(11 ) : 1216-1223.
  • 9Ahmed N, Riley C, Rice G, et al. Role of integrin recptors for fibronetin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment [J]. Clin Exp Metastasis, 2005,22 (4) : 391-402.
  • 10MaxR, Gerritsen RR, Nooijen PT, et al. Immunohistochemical analysis of integrin expression on tumor associated vessels of human carcinomas[J]. Int J Cancer, 1997,71 (3) :320-324.

二级参考文献17

  • 1Janmi R.Fionn GC,Andrcw L W. A.rat model of pancreatic ductal adenocarcionotua:Targeting chemical carcinogens[J].Surgery.1997.122:82-90.
  • 2Clapper ML.Wood M.Leaby K.Chemopreventive netivity of al tipraz agaipst N nitrosobis(2-oxypropy 1)amine(BOP)inducd ductal pancrcatic carcinoma dcyelopment and effecrs on survival of Syrian golden hamsters[J].Carcinogenesis,1995.16:2159-2160.
  • 3Thonpson HJ and meeker LD.Induction of mammnry gland carcinomas bytue subcutioneous injection of I Meth I notrosouren[J].Cancer Res.1983.43:1628.
  • 4Aberer W.Wolff Schremer EC.Stingl G.et al.Aratbioprine in the tremment of pemphigus yulgaris[J].J Am Acad Dermatol,1987,16:527.
  • 5Trikha M,Zhou Z,Nemeth JA,et al.CNTO 95,a fully human monoclonal antibody that inhibits αV integrins,has antitumor and antiangiogenic activity in vivo[J].Int J Cancer,2004,110:326-335.
  • 6Sun X,Kanwar JR,Leung E,et al.Gene transfer of antisense hypoxia reduciblefactor-1 enhances the therapeutic efficacy of cancer immunotherapy[J].Gene Ther,2001,8:638-645.
  • 7C Jasparini G,Brooks PC,Biganzoli E,et al.Vascular mtegrin αVβ3:a new prognostic indicator in breast cancer[J].Clin Cancer Res,1998,4:2625-2634.
  • 8Kawashima A,Tsugawa S,Boku A,et al.Expression of alpha V integrin family ingastric carcinomas:increased alphav beta6 is associated with lymphnode metastasis[J].Pathoi Res Pract,2003,199(2):57-64.
  • 9Takano S,Tsuboi K,Tomono Y,et al.Tissue factor,osteopontin,alphav beta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression[J].Br J Cancer,2000,82(12):1967-1973.
  • 10Ria R,Vacca A,Ribatti D,et al.Alpha(v)beta(3) integrinengagement enhances cell invasiveness in human multiple myeloma[J].Haematologica,2002,87 (8):836-845.

共引文献38

同被引文献98

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部